» Articles » PMID: 39448904

Establishment of a Prediction Model for Venous Thromboembolism in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Based on Serum Homocysteine Levels and Wells Scores: a Retrospective Cohort Study

Overview
Publisher Biomed Central
Date 2024 Oct 25
PMID 39448904
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We evaluated the diagnostic value of homocysteine (Hcy) levels combined with the Wells score and established a prediction model for venous thromboembolism (VTE) occurrence in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) based on the Hcy level and the Wells score.

Patients And Methods: Clinical information from 914 patients with AECOPD was retrospectively collected in our hospital from June 2020 to October 2023. Receiver operating characteristic curves were plotted to evaluate the diagnostic ability of Hcy concentrations combined with Wells scores and the prediction ability of the model. Univariate and multivariate logistic regressions were used to explore the effects of Hcy levels and the Wells score on VTE occurrence. A nomogram was established for individual risk evaluation.

Results: Hcy levels and Wells scores were significantly greater in the VTE group than in the non-VTE group (P < 0.001). The diagnostic ability of Hcy levels combined with the Wells score was greater than that Hcy levels or the Wells score alone. The AUC of the combined parameters was 0.935, with a sensitivity of 0.864 and a specificity of 0.855. Multivariate logistic regression indicated that elevated Hcy levels (OR:5.17, 95%CI: 3.76-7.09, P < 0.001) and Wells score (OR: 5.26, 95%CI: 3.22-8.59, P < 0.001) were independently associated with the risk of developing VTE in AECOPD patients. Decision curve analysis indicated that the net benefit of the nonadherence prediction nomogram was greater than that of the models adjusted for no or all variables, with a threshold of approximately 0.1-1.0.

Conclusions: The established prediction model can be used to evaluate an individual's risk of developing VTE on the basis of the Hcy level, Wells score, and clinical parameters. AECOPD patients may benefit from the early intervention based on estimated risk probability.

References
1.
Dong W, Zhu Y, Du Y, Ma S . Association between features of COPD and risk of venous thromboembolism. Clin Respir J. 2019; 13(8):499-504. DOI: 10.1111/crj.13051. View

2.
Fu X, Zhong Y, Xu W, Ju J, Yu M, Ge M . The prevalence and clinical features of pulmonary embolism in patients with AE-COPD: A meta-analysis and systematic review. PLoS One. 2021; 16(9):e0256480. PMC: 8412363. DOI: 10.1371/journal.pone.0256480. View

3.
Theodorakopoulou M, Bakaloudi D, Dipla K, Zafeiridis A, Boutou A . Vascular endothelial damage in COPD: current functional assessment methods and future perspectives. Expert Rev Respir Med. 2021; 15(9):1121-1133. DOI: 10.1080/17476348.2021.1919089. View

4.
Baqdunes M, Leap J, Young M, Kaura A, Cheema T . Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Crit Care Nurs Q. 2020; 44(1):74-90. DOI: 10.1097/CNQ.0000000000000341. View

5.
Rastoder E, Sivapalan P, Eklof J, Saeed M, Svorre Jordan A, Meteran H . Systemic Corticosteroids and the Risk of Venous Thromboembolism in Patients with Severe COPD: A Nationwide Study of 30,473 Outpatients. Biomedicines. 2021; 9(8). PMC: 8389624. DOI: 10.3390/biomedicines9080874. View